Clinical Trial

A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults

Name: A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults — clinical trial record (NCT07465965)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The specific aim of this study is to examine the Safety, Tolerability and Pharmacokinetic of Semaglutide Nasal Spray compared with placebo and positive control in Adult Overweight or Obese Participants.

Trial Details

NCT Number	NCT07465965
Lead Sponsor	Shanghai World Leader Pharmaceutical Co., Ltd.
Conditions	Overweight, Obesity
Enrollment	60 participants
Start Date	2026-03-02
Primary Completion	2026-08-21 (estimated)
Study Completion	2026-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-12